期刊文献+

UPLC-MS/MS测定人血浆中长春西汀和阿朴长春胺酸的含量及其应用

Determination of Vinpocetine and Apovincaminic Acid in Human Plasma by UPLC-MS/MS and Its Application
原文传递
导出
摘要 目的建立和验证UPLC-MS/MS测定人血浆中长春西汀和阿朴长春胺酸的方法,并用于临床样品检测。方法以长春西汀-d5、阿朴长春胺酸-d4为内标,人血浆样品经蛋白沉淀法沉淀处理,色谱柱为Waters ACQUITY UPLC?BEH C18(2.1 mm×50 mm,1.7μm),流动相为乙腈-水(含0.05%甲酸),梯度洗脱,流速0.35 mL·min^(-1);电喷雾离子化源正离子监测模式。结果长春西汀和阿朴长春胺酸线性范围分别为0.04~20.0 ng·mL^(-1)(r=0.9997)、0.50~250 ng·mL^(-1)(r=0.9996),检测限分别为0.01,0.10 ng·mL^(-1),待测物与内标提取回收率均为94.81%~105.0%,基质效应为94.51%~105.0%,RSD均<5%;批内、批间精密度RSD均<10%。结论本法特异性强、快速、准确,重复性好,适用于长春西汀临床生物样品检测及生物等效性研究。 OBJECTIVE To establish and validate a UPLC-MS/MS for the determination of vinpocetine and apovincaminic acid in human plasma and apply to the determination of clinical samples.METHODS Vinpocetine-d5 and apovincaminic acid-d4 were used as internal standards.Human plasma samples were prepared with acetonitrile to precipitate to protein.The chromatographic column was Waters ACQUITY UPLC?BEH C18(2.1 mm×50 mm,1.7μm),the mobile phase was acetonitrile-water(containing 0.05%formic acid).Gradient elution with a flow rate of 0.35 mL·min-1.Mass spectrometry conditions:Electrospray ionization source(ESI),positive ion detection mode.RESULTS The linear range were0.04-20.0 ng·mL^(-1)(r=0.9997)for vinpocetine and 0.50-250 ng·mL^(-1)(r=0.9996)for apovincaminic acid,and the limit of quantification were 0.01,0.10 ng·mL^(-1),respectively.The recoveries of test sample and internal standard were in the range of94.81%-105.0%,and the matrix effect were 94.51%-105.0%,RSDs were<5%.The RSDs of intra-and inter-batch precision were all<10%.CONCLUSION The method is specific,rapid,accurate and reproducible.Therefore,it is suitable for the determination of vinpocetine concentration in plasma and can applied to its bioequivalence study.
作者 张林琪 苏文俏 郭建军 游宇 胡林 周文 ZHANG Linqi;SU Wenqiao;GUO Jianjun;YOU Yu;HU Lin;ZHOU Wen(EverPro Medical Co.,Ltd.,Changsha 410205,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2023年第4期489-493,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 长春西汀 阿朴长春胺酸 血药浓度 超高效液相色谱串联质谱法 vinpocetine apovincaminic acid plasma concentration UPLC-MS/MS
  • 相关文献

参考文献4

二级参考文献23

  • 1CUIZP.Pharmacological effects and clinical application of vinpocetin .辽宁药物与临床,2002,5(1):68-69.
  • 2SZAKACS T, VERES Z, VERECZKEY L. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine[ J ]. Pol J Pharmacol, 2001,53(6) :623-628.
  • 3PUDLEINER P, VERECZKEY L. Study on the absorption of vinpocetine and apovincaminic acid[ J]. Eur J Drug Metab Pharmacokinet, 1993, 8(4) :317-321.
  • 4MISKOLCZI P, KOZMA K, POLGAR M, et al. Pharmacokinetics of vlnpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans [ J ]. Eur J Drug Metab Pharmacokinet, 1990,15 ( 1 ) : 1-5.
  • 5LAURIAN V. SILVIA I, SORIN L New HPLC-MS method for quantitative determinallon of apovincaminic acid in human plasma [ J ].J Sep Sci, 2006,29 (3) :385-389.
  • 6CHEN J, CU1 J, TAO W X, et al. Determination of apovineaminic aeid in human plasma by high-performanee liquid chromatography using solid-phase extraction and uhraviolet detection [ J]. J Chromatogr B, 2006,18 ( 2 ) :201-206.
  • 7MANUELA T M, JOAO P P, HENRIQUE M A, et al. Determination of apovinc, aminic acid in human plasma by high-performance liquid chromatography[ J ]. J Pharm Biomed Anal, 1996,14(5 ) : 617-622.
  • 8伍丽萍,李铜铃,贾毅敏,崔彦,陈聪,叶利明.LC-MS/MS测定人血浆中长春西汀体内代谢物阿朴长春胺酸[J].中国药学杂志,2010,45(6):458-460. 被引量:7
  • 9张兰华,曹文强,刘贺之.近年来长春西汀临床研究及应用进展[J].中华中医药杂志,2010,25(12):2070-2075. 被引量:34
  • 10鲁文琴.长春西汀的药理作用与临床应用[J].中国现代药物应用,2011,5(13):118-119. 被引量:21

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部